WallStreetZenWallStreetZen

NYSE: LLY
Eli Lilly & Co Stock Forecast, Predictions & Price Target

Open Broker Account
OverviewForecast
EarningsDividendOwnership

Analyst price target for LLY

Based on 13 analysts offering 12 month price targets for Eli Lilly & Co.
Min Forecast
$236.00-27.01%
Avg Forecast
$338.31+4.63%
Max Forecast
$412.00+27.42%

Should I buy or sell LLY stock?

Based on 13 analysts offering ratings for Eli Lilly & Co.
Strong Buy
Strong Buy
8 analysts 61.54%
Buy
3 analysts 23.08%
Hold
2 analysts 15.38%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their LLY stock forecasts and price targets.

LLY stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
UBS
Top 34%
67
Strong BuyUpgrades$363.00+12.26%2022-09-22
Morgan Stanley
Top 17%
84
Strong BuyMaintains$412.00+27.42%2022-09-07
BMO Capital
Top 48%
53
BuyMaintains$396.00+22.47%2022-09-06
Barclays
Bottom 16%
16
Strong BuyMaintains$355.00+9.79%2022-07-07
JP Morgan
Bottom 15%
15
Strong BuyMaintains$355.00+9.79%2022-06-01
SVB Leerink
Top 13%
88
BuyInitiates Coverage On$341.00+5.46%2022-05-23
Mizuho
Top 11%
90
Strong BuyMaintains$356.00+10.10%2022-05-02
BMO Capital
Bottom 10%
10
BuyMaintains$358.00+10.72%2022-04-29
Anonymous
Morgan Stanley
Strong BuyMaintains$369.00+14.12%2022-04-29
Wells Fargo
Top 16%
85
HoldMaintains$305.00-5.67%2022-04-29

1 of 2

Forecast return on equity

Is LLY forecast to generate an efficient return?
Company
189.37%
Industry
91.67%
Market
121.74%
LLY's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is LLY forecast to generate an efficient return on assets?
Company
34.38%
Industry
17.84%
LLY is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

LLY earnings per share forecast

What is LLY's earnings per share in the next 3 years based on estimates from 8 analysts?
Avg 1 year Forecast
$7.96+26.55%
Avg 2 year Forecast
$9.33+48.33%
Avg 3 year Forecast
$12.82+103.82%
LLY's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

LLY revenue forecast

What is LLY's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$28.8B-0.88%
Avg 2 year Forecast
$30.8B+5.85%
Avg 3 year Forecast
$35.6B+22.55%
LLY's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

LLY earnings growth forecast

How is LLY forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
24.95%
Industry
13.64%
Market
16.88%
LLY's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
LLY's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
LLY's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

LLY revenue growth forecast

How is LLY forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
7.01%
Industry
0.94%
Market
8.59%
LLY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
LLY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

LLY vs General Drug Manufacturer Stocks

TickerPricePrice TargetUp/downsideConsensus
LLY$323.35$338.31+4.63%Strong Buy
PFE$43.76$56.17+28.35%Buy
ABBV$134.21$161.31+20.19%Buy
MRK$86.12$99.39+15.40%Buy
JNJ$163.36$183.82+12.52%Buy
View Top General Drug Manufacturer Stocks

Eli Lilly & Co Stock Forecast FAQ

Is Eli Lilly & Co Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 13 Wall Street analysts covering (NYSE: LLY) stock is to Strong Buy LLY stock.

Out of 13 analysts, 8 (61.54%) are recommending LLY as a Strong Buy, 3 (23.08%) are recommending LLY as a Buy, 2 (15.38%) are recommending LLY as a Hold, 0 (0%) are recommending LLY as a Sell, and 0 (0%) are recommending LLY as a Strong Sell.

If you're new to stock investing, here's how to buy Eli Lilly & Co stock.

What is LLY's earnings growth forecast for 2022-2024?

(NYSE: LLY) Eli Lilly & Co's forecast annual earnings growth rate of 24.95% is forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 13.64%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 16.88%.

Eli Lilly & Co's earnings in 2022 is $5,691,600,000.On average, 8 Wall Street analysts forecast LLY's earnings for 2022 to be $7,563,391,543, with the lowest LLY earnings forecast at $7,439,868,817, and the highest LLY earnings forecast at $7,648,907,277. On average, 9 Wall Street analysts forecast LLY's earnings for 2023 to be $8,865,131,043, with the lowest LLY earnings forecast at $7,924,457,974, and the highest LLY earnings forecast at $9,311,713,207.

In 2024, LLY is forecast to generate $12,181,241,154 in earnings, with the lowest earnings forecast at $11,953,199,198 and the highest earnings forecast at $12,618,321,570.

What is LLY's revenue growth forecast for 2022-2024?

(NYSE: LLY) Eli Lilly & Co's forecast annual revenue growth rate of 7.01% is forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 0.94%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.59%.

Eli Lilly & Co's revenue in 2022 is $29,070,700,000.On average, 5 Wall Street analysts forecast LLY's revenue for 2022 to be $27,379,294,003,079, with the lowest LLY revenue forecast at $27,289,970,919,057, and the highest LLY revenue forecast at $27,565,426,598,505. On average, 5 Wall Street analysts forecast LLY's revenue for 2023 to be $29,238,545,725,719, with the lowest LLY revenue forecast at $28,476,739,265,490, and the highest LLY revenue forecast at $29,864,860,107,568.

In 2024, LLY is forecast to generate $33,850,149,837,267 in revenue, with the lowest revenue forecast at $32,908,354,611,978 and the highest revenue forecast at $34,508,144,947,865.

What is LLY's forecast return on assets (ROA) for 2022-2025?

(NYSE: LLY) forecast ROA is 34.38%, which is higher than the forecast US Drug Manufacturers - General industry average of 17.84%.

What is LLY's Price Target?

According to 13 Wall Street analysts that have issued a 1 year LLY price target, the average LLY price target is $338.31, with the highest LLY stock price forecast at $412.00 and the lowest LLY stock price forecast at $236.00.

On average, Wall Street analysts predict that Eli Lilly & Co's share price could reach $338.31 by Sep 22, 2023. The average Eli Lilly & Co stock price prediction forecasts a potential upside of 4.63% from the current LLY share price of $323.35.

What is LLY's Earnings Per Share (EPS) forecast for 2022-2024?

(NYSE: LLY) Eli Lilly & Co's current Earnings Per Share (EPS) is $6.29. On average, analysts forecast that LLY's EPS will be $7.96 for 2022, with the lowest EPS forecast at $7.83, and the highest EPS forecast at $8.05. On average, analysts forecast that LLY's EPS will be $9.33 for 2023, with the lowest EPS forecast at $8.34, and the highest EPS forecast at $9.80. In 2024, LLY's EPS is forecast to hit $12.82 (min: $12.58, max: $13.28).

What is LLY's forecast return on equity (ROE) for 2022-2025?

(NYSE: LLY) forecast ROE is 189.37%, which is considered strong.
©2022 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContact
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market Industries
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.